Feasibility Study With the Sirolimus-Eluting BX Velocity Balloon-Expandable Stent in the Treatment of Diabetic Patients With Native Coronary Artery Lesions

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

August 31, 2002

Study Completion Date

May 31, 2004

Conditions
Peripheral Vascular Diseases
Interventions
DEVICE

Sirolimus-Eluting BX Velocity Balloon-Expandable Stent

Trial Locations (11)

32803

Florida Hospital, Orlando

50400

National Heart Institute, Kuala Lumpur

64111

St Luke's Hospital, Kansas City

92037

Foundation for Cardiovascular Medicine, La Jolla

110062

Batra Hospital & Research Centre, New Delhi

168752

National Heart Center, Singapore

600006

Apollo Hospital, Chennai

02215

Beth Israel Deaconess Medical Center, Boston

Unknown

Queen Mary Hospital, Hong Kong

400 026

Jaslok Hospital & Research Centre, Mumbai

110 025

Escorts Heart Institute & Research Centre, New Delhi

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Cordis Corporation

INDUSTRY